Aspeya

Aspeya is a leading pharmaceutical manufacturing company committed to making a positive difference in the lives of patients and consumers through cutting-edge science, deep insight, and continuous innovation. Aspeya strives to empower healthier lifestyles and address specific unmet needs by optimizing formulas and applying rigorous scientific standards.

Aspeya's expertise drives innovation in four key areas: consumer health, cannabinoids, inhaled therapeutics, and nicotine replacement therapy. The company is dedicated to reimagining how ingredients are used and working towards the development and commercialization of a robust pipeline of wellness and healthcare products and brands. With locations including its primary office in Stamford, US, as well as Lausanne, Basel, and Neuchâtel in Switzerland; Copenhagen and Vejle in Denmark; London, Great Britain; Mumbai and Goa in India; Vancouver, Canada; Singapore; and Kuala Lumpur, Malaysia, Aspeya is strategically positioned for global impact.

Aspeya’s open-minded thinkers, leading-edge scientists, and knowledgeable innovators are focused on delivering high-quality pharmaceutical solutions worldwide. The company is dedicated to improving global health and wellness through its commitment to scientific excellence and product innovation. Aspeya continuously seeks opportunities to expand its reach and enhance its offerings. Company information will be completed soon with the support of the company’s management.

We invite the management of Aspeya to create a customized and exclusive company showcase and product listing on our platform.